LONDON - Another UK biotech bit the dust as Hunter-Fleming Ltd. was acquired by Newron Pharmaceuticals SpA in an all share transaction, after trying for a year, and failing, to raise fresh capital on its own account. (BioWorld International)

The management of Pharmexa A/S is starting to scout around for whatever "strategic alternatives" may be available to the company, following the completion of a rights issue that grossed DKK91.2 million (US$18 million). (BioWorld International)